InvestorsHub Logo

jfk

Followers 4
Posts 380
Boards Moderated 0
Alias Born 05/10/2007

jfk

Re: None

Friday, 12/08/2017 2:38:41 PM

Friday, December 08, 2017 2:38:41 PM

Post# of 3057
Today's Alzheimer news puts CDXC in a new league. For anyone with a relative with this disease, there is NOTHING in the marketplace that can remotely help. If Rudi Tanzi, the foremost Alz. authority in possibly the world, gives his thumbs up for NR to be "studied", he is signaling that this is ok to give to your folks...no harm, no foul. For a $100-$500 investment, without the need of going to a physician to get prescribed worthless/harmful RX drugs, you can experiment with NR and possibly achieve beneficial results. Adult nutrition drinks cost just as much, and I don't believe there is any science to back up their helpfulness. There will be 10,000's of new prescribers/users in 2018, once these learnings hit social media and get some play. Normal Valuations are going to become moot. I can now easily see the analyst $70M+ revenue projections in 2018 being met. It is becoming a lot clearer why our nameplate investors have come to the party.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News